Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right NowThe Motley Fool • 06/27/26
Here's How Many Shares of Pfizer You Must Own to Get $5,000 in Yearly DividendsThe Motley Fool • 06/27/26
MRK Gets EU Nod for Keytruda & Padcev Combination in Bladder CancerZacks Investment Research • 06/25/26
FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline MaintenanceBusiness Wire • 06/24/26
Forget Novo Nordisk. Pfizer's Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait24/7 Wall Street • 06/23/26
Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with AnalystsBusiness Wire • 06/23/26
Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung CancerBusiness Wire • 06/22/26
Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow24/7 Wall Street • 06/22/26
Pfizer Isn't Expecting to Make Any Big Acquisition in the Next Couple of Years, but It's Planning to Do This InsteadThe Motley Fool • 06/22/26